Curis
CRIS
#11067
Rank
S$5.75 M
Marketcap
S$0.61
Share price
-23.59%
Change (1 day)
-58.97%
Change (1 year)

P/E ratio for Curis (CRIS)

P/E ratio as of November 2026 (TTM): -0.0330

According to Curis's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.0330098. At the end of 2025 the company had a P/E ratio of -0.0415.

P/E ratio history for Curis from 2001 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2025-0.041590.49%
2024-0.0218-69.17%
2023-0.070656.98%
2022-0.0450-90.55%
2021-0.4760-22.12%
2020-0.6112597.48%
2019-0.0876151.46%
2018-0.0348
2016-0.342217.6%
2015-0.2910-18.52%
2014-0.3571-62.01%
2013-0.94009.62%
2012-0.8575-56.03%
2011-1.95

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Pfizer
PFE
38.8-117,606.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
12.9-39,200.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-2.86 8,567.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
19.0-57,737.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-6.43 19,371.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-0.4623 1,300.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-1.02 2,995.54%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.